AI Stocks & Markets

Today's Stories

1. 1

   KLA fair value $232.43 sees 24% undervalued on AI backlog

   Simply Wall St's most-followed KLA narrative sets fair value at $232.43 versus a $176.99 close, with the stock up 4.74% last session but down 34.24% over 90 days. That gap frames the AI equipment debate in pricing terms, and bulls lean on KLA's AI-driven backlog and profit base to argue the retreat is overdone.

   The bull case hinges on whether tariffs and any further China revenue slowdown undercut the backlog story. Note KLA's 47.9x P/E is above peers at 45.3x and the 39.9x fair ratio.

2. 2

   Broadcom's $230 billion AI chip outlook outpaces Nvidia's 70% growth

   Broadcom projected roughly $58 billion in AI semiconductor revenue for fiscal 2026, about $115 billion in fiscal 2027 and $230 billion in fiscal 2028, while Nvidia guided fiscal 2028 total revenue growth of about 70%. Broadcom's forecast implies two consecutive doublings and is the more aggressive of the two outlooks, though its AI business relies on a smaller number of massive custom-chip customers, which carries greater risk if a major buyer pulls back.

   The headline growth rate may not tell the whole story — Nvidia's slower-but-broader expansion, spanning cloud giants, governments, start-ups and enterprises, could prove more durable over the long run. Watch whether Broadcom's concentrated customer base holds up.

3. 3

   Berkshire's 48 million Alphabet buy makes it third-largest holding

   Berkshire Hathaway's latest 13F filing, covering holdings as of June 30, shows it bought more than 48 million Alphabet shares across both share classes in Q2, making Alphabet its third-largest stock position at about 12.6% of its equity portfolio. A roughly 12.6% portfolio weight is a strong signal of confidence in Alphabet from a conglomerate known for long holding periods.

   The filing data is as of June 30 and may be outdated; the test is whether Berkshire keeps or adds to the Alphabet stake in future disclosures.

4. 4

   Aehr Test Systems slips 15.2% as KLA grows 11.7%

   Aehr Test Systems reported FY2026 revenue of $50.0 million, down 15.2% from the prior year, and a net loss of $7.1 million. KLA posted FY2026 revenue of $13.6 billion, up 11.7%, with $4.8 billion in net income. The two AI-linked chip-equipment suppliers moved in opposite directions: Aehr's smaller, specialized business shrank and lost money, while KLA's larger, diversified operation grew profitably.

   Whether Aehr's bet on silicon carbide and high-bandwidth memory can turn its negative $5.4 million free cash flow around, while KLA's Taiwan Semiconductor Manufacturing Company relationship, more than 10% of its revenue, remains a concentration risk.

5. 5

   Palantir's most-followed narrative says 3% overvalued at $171.06 vs $176.18 close

   After AI partnerships with Method Security, NVIDIA and Nebius, Palantir's most-followed fair-value narrative put it at $171.06 versus a $176.18 last close, calling it 3% overvalued, while a DCF model saw it 5.8% below a $187.06 cash-flow value. With the price already above the crowd's fair value but below the cash-flow estimate, investors holding the stock face a debate over whether that premium can be supported, and the body notes valuation could unravel quickly if execution stumbles.

   The split hinges on which lens investors trust more — the crowd's user-driven narrative or the DCF's cash-flow estimate. The central figure to track is the $176.18 last close against those two fair-value marks.

6. 6

   Qualcomm AI Pivot Article Contains Only Disclosures

   The article titled 'Qualcomm's AI Pivot Has A Problem' contains no reporting; its body is limited to an analyst disclosure and a Seeking Alpha disclosure. Readers looking for Qualcomm's AI strategy details will find none — the body offers no facts, figures, or claims about the company.

   This item provides no dates, numbers, or events to track; any Qualcomm AI news would have to come from a different source.